Back to results
US 2024/0199737 A1Published application
GP130 Binding Molecules and Methods of Use
AssigneeSynthekine, Inc.
InventorsRobert Kastelein, Deepti Rokkam, Patrick J. Lupardus, Sandro Vivona
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to biologically active molecules comprising a single domain antibody (sdAb) that specifically binds to the extracellular domain of human gp130, compositions comprising such antibodies, and methods of use thereof.
Claims18
A gp130 binding molecule that specifically binds to the extracellular domain of gp130, wherein the gp130 binding molecule is a single domain antibody.
(canceled)
Dependencies are inferred from the claim text.